Mechanisms of Protection in the Brain by Physical Exercise in Polg Mutator Mice

Polg 突变小鼠体育锻炼的大脑保护机制

基本信息

  • 批准号:
    8550835
  • 负责人:
  • 金额:
    $ 20.99万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-09-25 至 2014-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Physical exercise is inversely related to the risk of Parkinson's disease (PD), and in rodents can protect against mitochondrial dysfunction and neuronal loss induced by MPTP. Recently, exercise also has been shown to have a dramatic protective effect in Polg "mutator" mice expressing a proofreading deficient form of the mitochondrial DNA (mtDNA) polymerase ¿ (Polg). In these mice, there is an accelerated accumulation of somatic mtDNA mutations, leading to a premature aging phenotype. Exercise in these mice normalizes muscle mitochondrial function and significantly extends lifespan. Perhaps more surprisingly, physical exercise also improves brain mitochondrial function and completely prevents brain atrophy. The mechanisms of these protective effects in the brain are unknown. In skeletal muscle, exercise increases levels of mRNA of PGC-1¿, a transcriptional coactivator that upregulates mitochondrial biogenesis and antioxidant defenses. Exercise also may increase PGC-1¿ activity through posttranslational mechanisms. In muscle, exercise reduces levels of RIP140, a suppressor of PGC-1¿ activity, and induces SIRT1 dependent deacetylation of PGC-1¿, thereby promoting its activation. We hypothesize that the protective effects of exercise on brain mitochondrial function exercise may result from similar mechanisms that account for this effect in muscle. If correct, then these mechanisms may account for the association of exercise with a reduced risk of PD. This potential link between exercise and increased PGC-1¿ activity is particularly exciting in light of recent data implicating reduced brai PGC-1¿ activity in the pathogenesis of PD. Thus, increasing PGC-1¿ in brain is a promising potential neuroprotective strategy. The Polg mutator mice represent a valuable model for studying the protective effects of exercise on the brain. In addition to brain atrophy and impaired mitochondrial function, we have preliminary data indicating that the Polg mutator mice have significant behavioral (motor) deficits as well as loss of striatal tyrosine hydroxylase (TH) immunostaining intensity and reduced dopamine (DA) and dopamine metabolites, indicating that mitochondrial dysfunction caused by somatic mtDNA mutation accumulation can cause nigral-striatal pathology. These data raise the possibility that the high levels of somatic mtDNA mutations that we and others have identified in SN neurons in PD may contribute to nigral-striatal dysfunction in PD. Thus, if our hypothesis proves to be correct, then the proposed studies on the impact of exercise on somatic mtDNA mutations and PGC-1¿ activity in the brain may be of relevance to PD. The main goal of this project is to investigate potential mechanisms of the protective effect of physical exercise in the brain of Polg mutator mice, including the impact on somatic mtDNA mutation levels and on regulation of PGC-1¿ levels and activity in the brain. This targeted approach will be complemented by an unbiased metabolomics approach that may reveal a role for novel pathways linking exercise to protective effects in the brain.
描述(由申请人提供):体育锻炼与帕金森病(PD)的风险呈负相关,并且在啮齿动物中可以防止MPTP诱导的线粒体功能障碍和神经元损失。最近,运动也被证明对表达线粒体DNA(mtDNA)聚合酶<$(Polg)校对缺陷形式的Polg“mutator”小鼠具有显着的保护作用。在这些小鼠中,体细胞mtDNA突变加速积累,导致过早衰老表型。这些小鼠的运动使肌肉线粒体功能正常化,并显着延长寿命。也许更令人惊讶的是,体育锻炼还可以改善脑线粒体功能,完全防止脑萎缩。大脑中这些保护作用的机制尚不清楚。在骨骼肌中,运动增加了PGC-1的mRNA水平,PGC-1是一种转录辅激活因子,可以上调线粒体生物合成和抗氧化防御。运动也可能通过翻译后机制增加PGC-1的活性。在肌肉中,运动降低了RIP 140的水平,RIP 140是PGC-1的活性抑制剂,并诱导PGC-1的SIRT 1依赖性脱乙酰化,从而促进其活化。我们推测,运动对脑线粒体功能的保护作用运动可能是由于类似的机制,解释了这种作用在肌肉。如果正确的话,那么这些机制可以解释运动与PD风险降低的关联。运动和PGC-1活性增加之间的这种潜在联系特别令人兴奋,因为最近的数据表明PD发病机制中脑PGC-1活性降低。因此,增加脑中的PGC-1是一种有前途的潜在神经保护策略。Polg mutator小鼠是研究运动对大脑保护作用的有价值的模型。除了脑萎缩和受损 通过研究线粒体功能,我们有初步数据表明Polg突变小鼠具有显著的行为(运动)缺陷以及纹状体酪氨酸羟化酶(TH)免疫染色强度的丧失和多巴胺(DA)和多巴胺代谢物的减少,表明由体细胞mtDNA突变积累引起的线粒体功能障碍可导致黑质-纹状体病理学。这些数据提出了一种可能性,即我们和其他人在PD的SN神经元中发现的高水平的体细胞mtDNA突变可能有助于PD的黑质-纹状体功能障碍。因此,如果我们的假设被证明是正确的,那么关于运动对脑中体细胞mtDNA突变和PGC-1?活性影响的拟议研究可能与PD相关。该项目的主要目标是研究体育锻炼对Polg mutator小鼠大脑的保护作用的潜在机制,包括对体细胞mtDNA突变水平的影响以及对PGC-1水平和大脑活性的调节。这种有针对性的方法将得到无偏见的代谢组学方法的补充,该方法可能揭示将运动与大脑保护作用联系起来的新途径的作用。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID K. SIMON其他文献

DAVID K. SIMON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID K. SIMON', 18)}}的其他基金

USP30 Inhibition as a Therapeutic Strategy in Parkinson's Disease
USP30 抑制作为帕金森病的治疗策略
  • 批准号:
    10809860
  • 财政年份:
    2023
  • 资助金额:
    $ 20.99万
  • 项目类别:
Mitochondrial mechanisms and vulnerability to alpha-synuclein toxicity
线粒体机制和α-突触核蛋白毒性的脆弱性
  • 批准号:
    9385532
  • 财政年份:
    2017
  • 资助金额:
    $ 20.99万
  • 项目类别:
PGC-1alpha and Pitx3 as individual and combined targets for neuroprotection
PGC-1alpha 和 Pitx3 作为神经保护的单独和组合靶标
  • 批准号:
    9256551
  • 财政年份:
    2014
  • 资助金额:
    $ 20.99万
  • 项目类别:
PGC-1alpha and Pitx3 as individual and combined targets for neuroprotection
PGC-1alpha 和 Pitx3 作为神经保护的单独和组合靶标
  • 批准号:
    8828821
  • 财政年份:
    2014
  • 资助金额:
    $ 20.99万
  • 项目类别:
PGC-1alpha and Pitx3 as individual and combined targets for neuroprotection
PGC-1alpha 和 Pitx3 作为神经保护的单独和组合靶标
  • 批准号:
    8710863
  • 财政年份:
    2014
  • 资助金额:
    $ 20.99万
  • 项目类别:
PGC-1alpha and Pitx3 as individual and combined targets for neuroprotection
PGC-1alpha 和 Pitx3 作为神经保护的单独和组合靶标
  • 批准号:
    9049558
  • 财政年份:
    2014
  • 资助金额:
    $ 20.99万
  • 项目类别:
Mechanisms of Protection in the Brain by Physical Exercise in Polg Mutator Mice
Polg 突变小鼠体育锻炼的大脑保护机制
  • 批准号:
    8453923
  • 财政年份:
    2012
  • 资助金额:
    $ 20.99万
  • 项目类别:
Mitophagy-driven selection against heteroplasmic mitochondrial DNA mutations
线粒体自噬驱动的针对异质线粒体 DNA 突变的选择
  • 批准号:
    8323862
  • 财政年份:
    2011
  • 资助金额:
    $ 20.99万
  • 项目类别:
Mitophagy-driven selection against heteroplasmic mitochondrial DNA mutations
线粒体自噬驱动的针对异质线粒体 DNA 突变的选择
  • 批准号:
    8258212
  • 财政年份:
    2011
  • 资助金额:
    $ 20.99万
  • 项目类别:
Impact of Somatic Mitochondrial DNA Point Mutations in the Aging Brain
体细胞线粒体 DNA 点突变对大脑衰老的影响
  • 批准号:
    8118522
  • 财政年份:
    2010
  • 资助金额:
    $ 20.99万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 20.99万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 20.99万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 20.99万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 20.99万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 20.99万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 20.99万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 20.99万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 20.99万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 20.99万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 20.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了